Please assess the completion status of the following clinical trial:

Trial Title: Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Atrial Fibrillation, Radiofrequency catheter ablation scheduled~Exclusion Criteria:~* Clinical trial denied

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Continuous heparin infusion group (Type: ACTIVE_COMPARATOR): continuous group is given an initial intravenous heparin 100u/kg and then maintain heparin infusion during procedural.
- Intermittent heparin infusion group (Type: ACTIVE_COMPARATOR): Intermittent group is given an initial intravenous heparin 100u/kg. Then The ACT is tested every 30min with administration of additional heparin boluses and titration of the heparin drip based on the results and according to the judgment of the operating physician.

Based on this trial design, predict the completion outcome and termination type (if applicable).